Slide 1 Focus on the Role of Proteasome Inhibitors in the Management of Multiple Myeloma Sagar Lonial, MD Editor-In-Chief for Multiple Myeloma @Point of Care Professor, Vice…
Relapsed and Refractory Myeloma Case 2 James R. Berenson, MD Medical & Scientific Director Institute for Myeloma & Bone Cancer Research Los Angeles, CA Relapsed/Refractory…
* ANCO ASH Highlights 2007: Multiple Myeloma Joseph M. Tuscano, MD University of California, Davis * Abstracts [73] Bortezomib (Velcade )-Thalidomide-Dexamethasone (VTD)…
Kenneth C Anderson, MD Kraft Family Professor of Medicine, Harvard Medical School Chief, Division of Hematologic Neoplasia Director, Jerome Lipper Multiple Myeloma Center…